Observational studyBMC neurology2016

Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study.

Susan Friend et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.